The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Avutometinib/defactinib and gemcitabine/nab-paclitaxel combination in first-line metastatic pancreatic ductal adenocarcinoma: Updated safety and efficacy of a phase 1b/2 study (RAMP 205).
 
Kian-Huat Lim
Honoraria - CURIS
Patents, Royalties, Other Intellectual Property - Hold patent for targeting MK2 as a therapeutic strategy in pancreatic cancer.
 
Rachael Safyan
Honoraria - Curio Science
Consulting or Advisory Role - Agenus; Guardant Health; Ipsen; Mirati Therapeutics
Research Funding - Exelixis (Inst); Replimune (Inst); Verastem (Inst)
 
Kimberly Perez
Honoraria - Exelixis; Ipsen; Novartis
Consulting or Advisory Role - Celgene; Eisai; Helsinn Therapeutics/QED Therapeutics; Lantheus Medical Imaging
 
Kristen Spencer
Honoraria - Amplity Health; Bio Ascend Oncology; Dava Oncology
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; Caris Life Sciences; Exelixis; Genentech/Roche
Speakers' Bureau - American Cancer Society
Research Funding - BMS Foundation
Travel, Accommodations, Expenses - ASCO; Cholangiocarcinoma Foundation
 
Eileen O'Reilly
Consulting or Advisory Role - Abbvie (I); AstraZeneca; Autem Medical (I); Berry Genomics (I); BioNTech SE; Boehringer Ingelheim; Bristol-Myers Squibb/Celgene; Eisai (I); Exelixis (I); Genentech/Roche (I); Ipsen; J-Pharma (I); Merck; Merus; Novartis; QED Therapeutics (I); Revolution Medicines; SERVIER (I); Vector Health (I); Yiviva (I)
Research Funding - Agenus (Inst); Arcus Ventures (Inst); AstraZeneca/MedImmune (Inst); BioNTech (Inst); Bristol Myers Squibb (Inst); Digestive Care (Inst); Elicio Therapeutics (Inst); Genentech (Inst); Helsinn Healthcare (Inst); Parker Institute for Cancer Immunotherapy (Inst); Puma Biotechnology (Inst); QED Therapeutics (Inst); Revolution Medicines (Inst); Yiviva (Inst)
(OPTIONAL) Uncompensated Relationships - Thetis Pharma
 
Andrew Ko
Honoraria - MJH Life Sciences; Research to Practice
Consulting or Advisory Role - Arcus Biosciences; Astellas Pharma; Corcept Therapeutics; Eisai; FibroGen; GRAIL; Legend Biotech; Merus; RenovoRx; Revolution Medicines; Roche/Genentech; Tango Therapeutics
Research Funding - AbGenomics International (Inst); Apexigen (Inst); Arcus Biosciences (Inst); Astellas Pharma (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); CrystalGenomics (Inst); Genentech/Roche (Inst); Leap Therapeutics (Inst); Revolution Medicines (Inst); Verastem (Inst)
 
Ardaman Shergill
Honoraria - Biyantara Foundation; Cholangiocarcinoma Foundation; Colon Cancer Alliance; Colon Cancer alliance; Great Debates in GI cancers
Consulting or Advisory Role - Guardant Health; Ipsen; Iterion Therapeutics; Merus; Pfizer; Pfizer; Revolution Medicines; Takeda
Research Funding - Abbvie (Inst); Arcus Biosciences (Inst); Astellas Pharma (Inst); BMS (Inst); Clovis Oncology (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Gossamer Bio (Inst); Gritstone Bio (Inst); Hutchison MediPharma (Inst); Macrogenics (Inst); Merck (Inst); Oncologie (Inst); Pfizer (Inst); Pfizer (Inst); Seattle Genetics/Astellas (Inst); Seattle Genetics/Astellas (Inst); Takeda (Inst); TP Therapeutics (Inst); verastem (Inst)
Travel, Accommodations, Expenses - colon cancer alliance; Ipsen; Merus; Revolution Medicines; Takeda
 
Despina Siolas
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Natera
 
Mark O'Hara
Consulting or Advisory Role - Alligator Bioscience; Geneos; Merus; Natera; PsiOxus Therapeutics; Strike Bio
Research Funding - Arcus Biosciences (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Geistlich Pharma (Inst); Genmab (Inst); HiberCell (Inst); Lilly (Inst); Merck (Inst); Natera (Inst); Parker Institute for Cancer Immunotherapy (Inst); PsiOxus Therapeutics (Inst); Revolution Medicines (Inst)
Patents, Royalties, Other Intellectual Property - 23-10471: Methods Of Treating Cancer Using Soluble ?-Glucans and Cd40 Agonistic Monoclonal Antibodies
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Arathi Mohan
Stock and Other Ownership Interests - EI Dupont; Johnson and Johnson; Pfizer; Viatris
Research Funding - Verastem (Inst)
Travel, Accommodations, Expenses - DAVA Oncology
 
E. Gabriela Chiorean
Consulting or Advisory Role - AADi; Astellas Pharma; BPGbio; Bristol-Myers Squibb/Celgene; IgM Biosciences; Ipsen; Merus; Pfizer; Purple Biotech; Regeneron; Takeda
Research Funding - Affini-T Therapeutics (Inst); BioAtla; Boehringer Ingelheim (Inst); Erasca, Inc (Inst); FibroGen (Inst); Genentech (Inst); Gilead/Forty Seven (Inst); Lonza (Inst); Merck (Inst); Mirati Therapeutics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Merus
 
Manuel Hidalgo
Leadership - BMS; Guardant Health
Stock and Other Ownership Interests - Champions Oncology; InxMed; Nelum Corp.
Honoraria - Champions Oncology; Velavigo; Velavigo
Consulting or Advisory Role - InxMed; Oncomatrix
Research Funding - Incyte; Ranok Therapeutics; TopAl
Patents, Royalties, Other Intellectual Property - Royalties from Myriad for PALB2 patent
Travel, Accommodations, Expenses - BMS; Guardant Health
 
Sheena Clift
Employment - Verastem
Stock and Other Ownership Interests - Verastem
 
Vijeta Bhambhani
Employment - Verastem
Stock and Other Ownership Interests - Fractyl
Travel, Accommodations, Expenses - Sirtex Medical; Verastem
 
Stacey Hill
Employment - Agenus; Verastem
Stock and Other Ownership Interests - Agenus; Verastem
 
Jonathan Pachter
Employment - Verastem
Leadership - Verastem
Stock and Other Ownership Interests - Verastem
Travel, Accommodations, Expenses - Verastem
 
John Hayslip
Employment - Abbvie; I-Mab; Nektar; Verastem
Leadership - I-Mab; Verastem
Stock and Other Ownership Interests - Abbvie; I-Mab; Verastem
 
Scott Barrett
Employment - Verastem
 
Vincent Picozzi
Stock and Other Ownership Interests - Amgen; Cigna; Iovance Biotherapeutics; Johnson & Johnson; Lilly; McKesson; Thermo Fisher Scientific
Consulting or Advisory Role - Revolution Medicines; TriSalus Life Sciences
Research Funding - Abbvie; Amal Therapeutics; Astellas Pharma; FibroGen; Ipsen; NovoCure